Humacyte, Inc. (HUMA) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $884.0K | -43.8% |
| 2024 | $1.57M | -31.1% |
| 2023 | $2.28M | +117.6% |
| 2022 | $1.05M | +376.4% |
| 2021 | $220.0K | -30.8% |
| 2020 | $318.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $884.0K | -43.8% |
| 2024 | $1.57M | -31.1% |
| 2023 | $2.28M | +117.6% |
| 2022 | $1.05M | +376.4% |
| 2021 | $220.0K | -30.8% |
| 2020 | $318.0K | — |